Metformin Protects the Heart Against Hypertrophic and Apoptotic Remodeling After Myocardial Infarction
Cardiovascular complications are the most prevalent cause of morbidity and mortality in diabetic patients. Metformin is currently the first-line blood glucose-lowering agent with potential relevance to cardiovascular diseases. However, the underpinning mechanisms of action remain elusive. Here, we r...
Main Authors: | Halyna Loi, Frederic Boal, Helene Tronchere, Mathieu Cinato, Solomiia Kramar, Oleksandra Oleshchuk, Mykhaylo Korda, Oksana Kunduzova |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-02-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2019.00154/full |
Similar Items
-
Metformin Attenuates Postinfarction Myocardial Fibrosis and Inflammation in Mice
by: Halyna Loi, et al.
Published: (2021-08-01) -
Galanin promotes autophagy and alleviates apoptosis in the hypertrophied heart through FoxO1 pathway
by: Ilenia Martinelli, et al.
Published: (2021-04-01) -
Role of Foxo1 gene expression in mechanism of antihypertrophic action of metformin in cardiomyocytes
by: N.V. Pasiechko, et al.
Published: (2018-10-01) -
PI5P Triggers ICAM-1 Degradation in Shigella Infected Cells, Thus Dampening Immune Cell Recruitment
by: Frédéric Boal, et al.
Published: (2016-02-01) -
IL-26 in the induced sputum is associated with the level of systemic inflammation, lung functions and body weight in COPD patients
by: Savchenko L, et al.
Published: (2018-08-01)